Session » RA – Diagnosis, Manifestations, & Outcomes Poster I
- 10:30AM-12:30PM
-
Abstract Number: 0492
A Machine Learning Model for the Early Identification of Rheumatoid Arthritis: Development and Validation
- 10:30AM-12:30PM
-
Abstract Number: 0498
ACPA Subtypes, RF Isotypes, and the Risk of Rheumatoid Arthritis-Associated Interstitial Lung Disease
- 10:30AM-12:30PM
-
Abstract Number: 0493
An Algorithm Pipeline for Automated Metrical Analysis of Joint Swelling in Rheumatoid Arthritis via Smartphone Hand Photographs
- 10:30AM-12:30PM
-
Abstract Number: 0474
Association Between Rheumatoid Arthritis and Survival After Cancer: A Systematic Literature Review and Meta-analysis
- 10:30AM-12:30PM
-
Abstract Number: 0488
Association of Anti-CarP Levels with Clinical Activity and Serological Profile in Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0486
Associations Between Frailty and Incident Cancer and Cancer-related Mortality in Veterans with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0476
Baricitinib in Rheumatoid Arthritis – Interstitial Lung Disease. National Multicenter Study of 72 Patients
- 10:30AM-12:30PM
-
Abstract Number: 0485
Biomarkers for Disease Activity and Response to Treatment in Early Rheumatoid Arthritis: Metabolomics and Machine Learning Analyses in NORD-STAR Cohort
- 10:30AM-12:30PM
-
Abstract Number: 0480
Can’t Sleep, Won’t Sleep: A Systematic Review and Meta-Analysis of Insomnia Prevalence in 70,105 Rheumatoid Arthritis Patients
- 10:30AM-12:30PM
-
Abstract Number: 0460
Cartilage Damage or (sub)luxation of Finger Joints: Impact on Physical Function in Patients with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0462
Circulating Mediators of Endothelial Dysfunction as Predictors of Incident Heart Failure in Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0484
Cluster Analysis Based on Joint Characteristics: A Study of Joint Involvement Profiles in Early Rheumatoid Arthritis (ERA) Patients in China
- 10:30AM-12:30PM
-
Abstract Number: 0461
Complete Description of the Three Pathways of the Complement System in a Series of 430 Patients with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0479
Constructing and Using a Novel Nucleotide Transformer for Patients with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0495
Correlation Between Triglyceride/Glucose Index and Functional Capacity in Rheumatoid Arthritis Patients
- 10:30AM-12:30PM
-
Abstract Number: 0481
Differential Effect of Comorbidities on the Clinical Evolution of Early Arthritis by Sex
- 10:30AM-12:30PM
-
Abstract Number: 0496
Dissecting Early RA Patient Trajectories Through Time-independent Disease State Identification Identifies Distinct Patterns Dissected by Inflammation in Blood or Joints
- 10:30AM-12:30PM
-
Abstract Number: 0482
Endothelial Dysfunction and QRISK3 in Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0463
Evaluation of Inflammatory Indices as Predictive Biomarkers of Carotid Plaque in Patients with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0473
Immune Checkpoint–Induced Arthritis: A Comprehensive Single Cohort Descriptive Analysis from Clinical Evaluation to Histology
- 10:30AM-12:30PM
-
Abstract Number: 0472
Impaired Cardiac Function in Contemporary Rheumatoid Arthritis Patients: A Comparative Pilot Study with Cardiovascular Magnetic Resonance-derived Strain Analysis
- 10:30AM-12:30PM
-
Abstract Number: 0490
Improvements in Peri-fracture Care in Rheumatoid Arthritis (RA) Have Offset Increased Mortality
- 10:30AM-12:30PM
-
Abstract Number: 0464
Increases in Paraoxonase-1 Activity over Time Associates with Reduced Risk of Incident Inflammatory Arthritis in an Anti-Citrullinated Protein Antibody-Positive Population
- 10:30AM-12:30PM
-
Abstract Number: 0466
Inpatient Outcomes of Rheumatoid Arthritis in Hospitalized Patients Using Cannabis: Data from the National Inpatient Sample
- 10:30AM-12:30PM
-
Abstract Number: 0458
Long-Term Outcomes in Seronegative Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0467
Lung Involvement in Early Rheumatoid Arthritis, Analysis of ERA UCLouvain Brussels FINDRA Cohort
- 10:30AM-12:30PM
-
Abstract Number: 0457
Metabolic Syndrome, Adipokines, and Response to Advanced Therapies in Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0470
New Approach for Early and Accurate Diagnosis of Rheumatoid Arthritis-related Interstitial Lung Disease: Matrix Metalloproteinases 7 and 9 as Novel Blood Biomarkers
- 10:30AM-12:30PM
-
Abstract Number: 0483
Obesity, Prednisone Use, and Patient-Reported Outcomes Are Predictors of Becoming Difficult-to-Treat in an RA Population Treated with a First-Line Biologic DMARD
- 10:30AM-12:30PM
-
Abstract Number: 0499
PD-1hiCXCR5-CD4+T Peripheral Helper Cells Enrich in Rheumatoid Arthritis and Predict Clinical Response to Anti-TNF Treatment
- 10:30AM-12:30PM
-
Abstract Number: 0468
Plasma Calprotectin Assessed in Multiple Biological Treatment Strategies for Early Rheumatoid Arthritis over 48 Weeks
- 10:30AM-12:30PM
-
Abstract Number: 0497
Relationship Between the Complement System and Subclinical Carotid Atherosclerosis in Patients with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0475
Rheumatoid Arthritis – Progressive Interstitial Lung Disease with Abatacept: Data from a Large National Multicenter Cohort
- 10:30AM-12:30PM
-
Abstract Number: 0469
SCORE2 Is Superior to SCORE in Predicting the Presence of Carotid Plaques and Intima-media Thickness in Rheumatoid Arthritis Patients: A Cross-sectional Study with Carotid Ultrasound
- 10:30AM-12:30PM
-
Abstract Number: 0478
Skin Sodium in Patients with Rheumatoid Arthritis: Association with Blood Pressure and Disease Activity
- 10:30AM-12:30PM
-
Abstract Number: 0491
Small Molecule Metabolites, Potential Disease-specific Biomarkers for Predicting Treatment Response in Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0477
The Global Prevalence of Interstitial Lung Disease in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-analysis
- 10:30AM-12:30PM
-
Abstract Number: 0487
The Triglyceride to HDL Ratio, a Surrogate Marker of Insulin Resistance, Predicts All Cause and Cardiovascular Mortality in Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0465
Therapeutic Drug Monitoring of the Adalimumab Biosimilar (AMJEVITA™, Adalimumab-atto) Using Originator Adalimumab and Anti-Adalimumab Antibody Assays
- 10:30AM-12:30PM
-
Abstract Number: 0459
Tocilizumab Demonstrates Superior Inhibition of MMP-Mediated Basement Membrane Collagen Degradation Compared to Methotrexate or Placebo
- 10:30AM-12:30PM
-
Abstract Number: 0471
Understanding the Role of the Complement System in Insulin Resistance and Metabolic Syndrome in Patients with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0489
Use of Chair Sit-to-Stand as a Pragmatic Alternative to Assess Frailty in Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0456
Use of Machine Learning to Evaluate Incremental Value of Actigraphy Data for Classifying Treatment Response in Patients with Rheumatoid Arthritis